glp 1 agonist shortage Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Shortage: Deterioration of Glycemic Control in Type 2 Diabetes GLP-1 Receptor Agonist National Shortage
Description
doi: 10.1111/jgh.12271
For patients primarily seeking weight management, either with or without type 2 diabetes, higher-dose formulations such as semaglutide 2.4 mg (Wegovy) or liraglutide 3 mg (Saxenda) may be more appropriate
The group has 4,000 members
A randomized double-blind trial found GLP-1 increased significantly in participants taking green tea extract versus placebo
Finck, B
doi: 10.1038/ijo.2011.158 [DOI] [PMC free article] [PubMed] [Google Scholar] 240
